Understanding Proscar 5 Organon Pharmaceuticals
Proscar 5 Organon Pharmaceuticals is a pharmaceutical finasteride compound manufactured by Organon Pharmaceuticals for in-vitro laboratory research applications. This compound represents a clinically-studied 5-alpha-reductase inhibitor that researchers can examine to investigate hormonal modulation pathways and enzyme inhibition mechanisms. Scientists at Stroid UK Shop utilise this compound to study the biochemical processes involved in androgenic hormone metabolism and cellular pathway modulation. Laboratory studies focus on understanding how finasteride interacts with 5-alpha-reductase enzymes and its subsequent effects on dihydrotestosterone production in controlled research environments.
Laboratory Investigation Applications
Research teams evaluate Proscar 5 for its inhibitory effects on 5-alpha-reductase type I and type II enzymes, studying how this mechanism reduces dihydrotestosterone synthesis in cellular models. Comparative studies alongside compounds from our aromatase inhibitors and finasteride category allow researchers to examine different hormonal modulation pathways. Scientists analyse the compound’s molecular interactions with steroid metabolism enzymes and investigate its potential applications in androgenic research protocols. Laboratory investigations often compare finasteride mechanisms with other research compounds available in our SARMs collection and peptides range to understand tissue-specific effects and enzymatic pathway differences.
Product Specifications
| Manufacturer | Organon Pharmaceuticals |
|---|---|
| Active Compound | Finasteride |
| Concentration | 5mg per unit |
| CAS Number | 98319-26-7 |
| Molecular Formula | C₂₃H₃₆N₂O₂ |
| Molecular Weight | 372.55 g/mol |
| Storage Requirements | Room temperature, dry environment |
| Research Classification | 5-alpha-reductase inhibitor |
Research Compliance Statement
Proscar 5 Organon Pharmaceuticals is supplied exclusively for in-vitro laboratory research purposes by qualified scientific institutions and licensed research facilities. This pharmaceutical compound is not intended for human consumption, therapeutic applications, or any use outside controlled laboratory environments. Researchers must maintain appropriate biosafety protocols and comply with institutional guidelines when handling this material. All studies should be conducted under proper laboratory supervision with adequate safety measures and documentation procedures.
